Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

An annual vaccine: seasonal influenza.

Jivapaisarnpong T, Krause PR.

Biologicals. 2009 Nov;37(6):410-1; discussion 421-3. doi: 10.1016/j.biologicals.2009.08.001. Epub 2009 Oct 21.

PMID:
19850497
2.

A vaccine measured with a highly variable assay: rabies.

Jivapaisarnpong T, Schofield T, Krause PR.

Biologicals. 2009 Nov;37(6):412-5; discussion 421-3. doi: 10.1016/j.biologicals.2009.08.002. Epub 2009 Oct 20.

PMID:
19846319
3.
4.

Vaccine stability study design and analysis to support product licensure.

Schofield TL.

Biologicals. 2009 Nov;37(6):387-96; discussion 421-3. doi: 10.1016/j.biologicals.2009.08.009. Epub 2009 Aug 29. Review.

PMID:
19717312
5.

Stability evaluation of vaccines.

Schofield T, Krause PR.

Biologicals. 2009 Nov;37(6):355. doi: 10.1016/j.biologicals.2009.09.001. Epub 2009 Sep 26. No abstract available.

PMID:
19783158
6.

Stability evaluation of vaccines: WHO approach.

Knezevic I.

Biologicals. 2009 Nov;37(6):357-9; discussion 421-3. doi: 10.1016/j.biologicals.2009.08.004. Epub 2009 Sep 3.

PMID:
19729320
7.

Stability post-licensure: compatibility container content - a practical case study.

Duchêne M, Jeanmart L, Slegers B.

Biologicals. 2009 Nov;37(6):407-9; discussion 421-3. doi: 10.1016/j.biologicals.2009.08.006. Epub 2009 Aug 29.

PMID:
19717309
8.

Goals of stability evaluation throughout the vaccine life cycle.

Krause PR.

Biologicals. 2009 Nov;37(6):369-78; discussion 421-3. doi: 10.1016/j.biologicals.2009.08.015. Epub 2009 Sep 22. Review.

PMID:
19775911
9.

WHO/KFDA workshop on stability evaluation of vaccines, Seoul, Korea, 23-25 April 2008.

Shin J, Smith D, Southern J, Knezevic I.

Biologicals. 2009 Nov;37(6):435-44; discussion 421-3. doi: 10.1016/j.biologicals.2009.08.018. Epub 2009 Sep 23.

PMID:
19783459
10.

Maintenance of vaccine stability through annual stability and comparability studies.

Schofield TL.

Biologicals. 2009 Nov;37(6):397-402; discussion 421-3. doi: 10.1016/j.biologicals.2009.08.010. Epub 2009 Aug 31. Review.

PMID:
19717311
11.

New vaccine approaches for seasonal and pandemic influenza.

Palache B.

Vaccine. 2008 Nov 18;26(49):6232-6. doi: 10.1016/j.vaccine.2008.07.022. Epub 2008 Jul 30. Review.

PMID:
18674583
12.

Consideration on a few aspects of the stability studies post licensure.

Pierard I, Spelte G, Le Tallec D, Duchêne M.

Biologicals. 2009 Nov;37(6):403-6; discussion 421-3. doi: 10.1016/j.biologicals.2009.08.011. Epub 2009 Oct 22. Review.

PMID:
19853472
13.

Challenges in the evaluation and licensing of new pneumococcal vaccines, 7-8 July 2008, Ottawa, Canada.

Feavers I, Knezevic I, Powell M, Griffiths E; WHO Consultation on Serological Criteria for Evaluation and Licensing of New Pneumococcal Vaccines.

Vaccine. 2009 Jun 8;27(28):3681-8. doi: 10.1016/j.vaccine.2009.03.087. Epub 2009 Apr 17.

PMID:
19442421
14.

Lessons learned: role of influenza vaccine production, distribution, supply, and demand--what it means for the provider.

Orenstein WA, Schaffner W.

Am J Med. 2008 Jul;121(7 Suppl 2):S22-7. doi: 10.1016/j.amjmed.2008.05.004. Review.

PMID:
18589064
15.

Basic principles of stability.

Egan W, Schofield T.

Biologicals. 2009 Nov;37(6):379-86; discussion 421-3. doi: 10.1016/j.biologicals.2009.08.012. Epub 2009 Aug 31.

PMID:
19720547
16.

A global pandemic influenza vaccine action plan.

Kieny MP, Costa A, Hombach J, Carrasco P, Pervikov Y, Salisbury D, Greco M, Gust I, LaForce M, Franco-Paredes C, Santos JI, D'Hondt E, Rimmelzwaan G, Karron R, Fukuda K.

Vaccine. 2006 Sep 29;24(40-41):6367-70.

PMID:
17240560
17.

Stability testing of vaccines: Developing Countries Vaccine Manufacturers' Network (DCVMN) perspective.

Jadhav SS, Dogar V, Gautam M, Gairola S.

Biologicals. 2009 Nov;37(6):360-3. doi: 10.1016/j.biologicals.2009.08.003. Epub 2009 Aug 29. Review.

PMID:
19717310
18.

Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Apr 18;57(15):393-8.

19.

Vaccination activity of live influenza vaccine in different seasons of the year.

Zykov MP, Sosunov AV.

J Hyg Epidemiol Microbiol Immunol. 1987;31(4):453-9.

PMID:
3429857
20.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinskiĭ AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832

Supplemental Content

Support Center